electroCore to Announce Second Quarter June 30, 2024 Financial Results on Wednesday, August 7, 2024
electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, has announced that it will release its financial results for the second quarter ended June 30, 2024, after the market closes on Wednesday, August 7, 2024.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, has announced that it will release its financial results for the second quarter ended June 30, 2024, after the market closes on Wednesday, August 7, 2024. The company will host a conference call and webcast at 4:30 PM EDT on the same day to discuss the financial results and address questions from investors and analysts.
Interested parties can access the conference call by dialing 877-407-8835 (domestic) or +1 201-689-8779 (international) and using the Conference ID: 13744119. A webcast of the earnings call will also be available for those who prefer to listen online.
Details
News Market Reaction – ECOR
The recorded move for ECOR in the trading session of this news was -0.80%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
ROCKAWAY, N.J., July 31, 2024 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, today announced that it will report financial results for the second quarter ended June 30, 2024, after the close of the market on Wednesday, August 7, 2024. Management will host a conference call and webcast at 4:30 PM EDT to discuss the financial results and answer questions.
Wednesday, August 7, 4:30 PM EDT
Dial-In: 877-407-8835 / +1 201-689-8779
Conference ID: 13744119
Webcast: electroCore Earnings Webcast
About electroCore, Inc.
electroCore, Inc. is a commercial stage bioelectronic medicine and wellness company dedicated to improving health through its non-invasive vagus nerve stimulation (“nVNS”) technology platform. Our focus is the commercialization of medical devices for the management and treatment of certain medical conditions and consumer product offerings utilizing nVNS to promote general wellbeing and human performance in the United States and select overseas markets.
For more information, visit www.electrocore.com.
Contact:
ECOR Investor Relations
(973) 302-9253
investors@electrocore.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.